Dr. Shapiro received a B.S. During her tenure, Sue built a robust Immunology development portfolio through internal discovery, and external licensing, and championed research into the emerging areas of the microbiome and immune repertoire profiling. He began his career with PricewaterhouseCoopers LLP and qualified as a chartered accountant. He then moved on to Princeton University as a National Institutes of Health Postdoctoral Fellow in the laboratory of Professor E. C. Taylor. Prior to joining Sanofi, he spent over 20 years with GlaxoSmithKline in Germany, Canada, France and, latterly, the U.S. as president of its North American pharmaceutical division. Welcome to the nondualist spirituality center for the greater Cleveland area - join us in studying Vedantic scripture and metaphysics in our biweekly sessions and scheduled special topics lectures from Ramakrishna Order monks. Dr. Olle received his B.S. She retired from her role as Global Therapeutic Area Head for Immunology at Janssen/J&J in 2017. Dr. LaMattina was previously president of Pfizer Global Research and Development and held positions of increasing responsibility during his 30-year career at Pfizer, including vice president of U.S. Chris leads debt, equity, and guarantee investments that support the Gates Foundation’s programs in global health and economic development. Ben Shapiro, M.D., is a co-founder of PureTech and a member of the R&D Committee. He has served on various advisory groups at MIT, Duke University and Queen’s University at Kingston, Ontario. Impairment On Oil & Gas Division. Troy A. Ignelzi joined Karuna Therapeutics as Chief Financial Officer in March 2019, bringing more than 25 years of experience supporting companies in finance, business development and operations. We demonstrate world-class standards of governance, safety, sustainability, and social responsibility. HSIL: The Board of Directors has decided to close the buyback with effect from closing hours of December 31, 2020. Approval of any appointments to or removals from the Board of Directors. He joins Karuna from scPharmaceuticals where, in his role as Chief Financial Officer, he helped oversee development from a privately-held clinical-stage company to a publicly-traded biopharma preparing for commercial launch. Vedanta Biosciences announced the appointment of Troy Ignelzi as an independent member of its Board of Directors. Dr. Shapiro previously served as a director of Celera Corporation. Prior to that, Dr. Chowrira held various leadership and management positions at Nektar Therapeutics (chief operating officer), Merck & Co, or Merck (vice president), Sirna Therapeutics (general counsel; acquired by Merck) and Ribozyme Pharmaceuticals (chief patent counsel). He most recently served as a General Manager of Bioprocessing Products, where he led the introduction of the company’s antibody drug production and service business lines, which later became core areas of JSR’s life science business unit. Director. CEO & Whole-time Director. in microbiology from the UAS, Bangalore, India. Mr. Ignelzi has more than 25 years of experience supporting life science companies in finance, business development and operations, and has helped oversee their evolutions from privately held, clinical-stage companies to publicly traded biopharmaceutical … Version approved by The Board of Directors of Vedanta Limited Effective Date th28 March 2019 VEDANTA LIMITED . and PhD. Non-Executive Director: Madhu … Vedanta is a globally diversified natural resources company with low cost operations. Non-Executive Director: Lalita D Gupte: Ind. Ending the War on Microbes | Bernat Olle | TEDxCambridge. His leadership resulted in the discovery, development and registration of approximately 25 drugs and vaccines. Prior to scPharmaceuticals, Mr. Ignelzi was a senior executive at Juventas Therapeutics, Esperion Therapeutics, and Insys Therapeutics, helping raise public/private capital, expand development pipelines through licensing/acquisition and advancing critical therapies, several of which are currently approved by the FDA. Vedanta reported a consolidated net loss of Rs 6,664 crore in fiscal year 2020 as against a net profit of Rs 7,065 crore in the previous financial year. He is also a trustee of Northeastern University and a member of the board of fellows at Stanford Medical School. Currently Sue is CEO of Aro Biotherapeutics, and serves on the Board of Directors of the Wistar Institute. Bharatt Chowrira, Ph.D., J.D., is the president and chief of business and strategy at PureTech. Chris Chen is a Principal at the Gates Foundation Strategic Investment Fund (SIF), which manages a $2.5 billion fund within the Gates Foundation. His last assignment with Vedanta was as CEO & Whole Time Director of Talwandi Sabo Power Limited during August 2008 to January 2012 and the 1980 MW Thermal Power Project was kick started under his leadership. As executive vice president at Merck Research Laboratories of Merck & Co., Dr. Shapiro initially led Worldwide Basic Research and was responsible for all the basic and preclinical research activities at Merck. Vedanta has bagged board of directors approval for interim dividend aggregating to Rs3,500cr for the financial year FY21. Posted on 11/24/2020 0 . He is the author of numerous scientific publications and U.S. patents. He received his bachelor’s degree in commerce from Queen’s University in Ontario, Canada. Chris Viehbacher, Chairman of Vedanta Biosciences’ Board of Directors and Managing Partner of Gurnet Point Capital said, “Dr. Bernat Olle, Ph.D. Chief Executive Officer. CAMBRIDGE, November 24, 2020 – Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced the appointment of Troy Ignelzi as an independent member of its Board of Directors. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. The board of directors of Anil Agarwal-led Vedanta Limited on Monday evening approved the delisting plan after reviewing the due diligence report dated May 18, … We empower our people to drive excellence and innovation to create value for our stakeholders. Dillon is a recognized leader in the field of immunology who brings an impressive track record from her tenure at Janssen Research & Development. Dr. Sue Dillon, PhD is co-founder, President and CEO of Aro Biotherapeutics, a start up biotech focused on developing and commercializing Centyrins, a proprietary protein drug platform with the potential to revolutionize delivery of diverse drug classes, including nucleic acids and genetic therapies. He was also a member of the International Business Council. Ms. Yatinder Prasad. Dr. LaMattina received a B.S. In 2013 Dr. Olle was named "Innovator of the Year" in MIT Technology Review Spain's "Innovators under 35" awards. Mr. Ignelzi holds a bachelor’s degree in Accounting from Ferris State University. That discretion of taking that decision rested with the board of directors, it said. in Chemistry from Dickinson College and his M.D. in chemistry from Boston College in 1971 and received a Ph.D. in organic chemistry from the University of New Hampshire in 1975. Vedanta: Promoters of Anil Agarwal-led Vedanta Ltd has pledged and encumbered their entire stake of 55.11 per cent equity with OCM Verde Investment in order to fund Vedanta Resources’ outstanding debt of $900 million and for acquisition of up to 11.5 per cent shares in Vedanta Ltd by the promoter group, Vedanta Mauritius. He also serves on the Scientific Advisory Board of Frequency Therapeutics and is a trustee associate of Boston College. He completed his doctoral work at the Chemical Engineering Department at MIT, where he developed a novel method for large-scale bacterial culture. Prior to joining PureTech, Dr. Chowrira was the president of Synlogic, Inc., a biopharmaceutical company focused on developing synthetic microbiome-based therapeutics, from September 2015 to February 2017, where he oversaw and managed corporate and business development, alliance management, financial, human resources, intellectual property and legal operations. ... Board of Directors. The Chinmaya Mission Toronto is committed to the highest standards of governance and the Board of Directors of the Toronto Mission believes that good governance practices are essential to the wellbeing of the Toronto Mission and all its stakeholder communities. {{HeaderData[0].chg}} {{HeaderData[0].perchg}}%. Director. Chris is the former CEO and member of the board of directors of Sanofi and was also the chairman of the board of Genzyme in Boston. He is also the chairman of PureTech’s board of directors. Past advocacy roles include: former co-chair with Bill Gates of the CEO Roundtable on Neglected Diseases; chairman of the CEO Roundtable on Cancer; chairman of the board of the Pharmaceutical Research and Manufacturers of America in Washington; and president of the European Federation of Pharmaceutical Industries and Associations in Brussels. At the World Economic Forum at Davos, Chris was a chair of the Health Governors and co-chaired an initiative to create a Global Charter for Healthy Living. Sue has 30 years in executive leadership roles at pharmaceutical and biotech companies. On Monday, May 18, Vedanta Ltd.’s board of directors will meet to consider the delisting proposal by promoter Vedanta Resources Ltd. Here’s a message to them from two governance advisory firms — act in the interest of minority shareholders.Vedanta’s independent directors have a fiduciary duty to guide shareholders on VRL’s delisting bid, said an Institutional Investor Advisory Services report. Atsushi joined JSR Corporation in 1989 and has since served in a variety of roles. ©2019 by Vedanta Center of Cleveland. Prior to joining Synlogic, Dr. Chowrira was the chief operating officer of Auspex Pharmaceuticals Inc., from 2013 to 2015, which was acquired by Teva Pharmaceuticals in the Spring of 2015. Mr. Arun Misra. Mr Navin Agrawal. Before joining the foundation, Chris was a Vice President on Bain Capital’s private equity investment team, where he invested in and provided operational support to companies across the healthcare, services, and industrials sectors. Discovery Operations in 1993, senior vice president of Worldwide Discovery Operations in 1998 and senior vice president of Worldwide Development in 1999. He also received the 2019 Barry M. Portnoy Immigrant Entrepreneur Award from The Immigrant Learning Center. The company has set October 31, 2020, as … PureTech Founded Entity Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Board of Directors Mr. Ignelzi brings strong financial and operational expertise to the board and will serve as chairman of the Audit Committee Dr. LaMattina serves on the board of directors of Ligand Pharmaceuticals, Zafgen, Inc. and Immunome Inc. and is chairman of the board of directors of Alivio Therapeutics, Inc. Sue received her PhD in Immunology from Thomas Jefferson University in Philadelphia, and completed a postdoctoral fellowship in Immunology at Duke University. {{HLdata.Fifty2WkHigh_adj|number:2}}{{HLdata.Fifty2WkHigh_adjDt}}, {{HLdata.Fifty2WkLow_adj|number:2}}{{HLdata.Fifty2WkLow_adjDt}}, If you have RSS reader, Please Cut and Paste the URL. ... to make serious efforts to move in a positive direction and the Group now has two female independent Non-Executive Directors on the Board of Vedanta Limited (formerly known as Sesa Sterlite Ltd/Sesa Goa Ltd). Chairman. Vedanta … The company has till date bought back 75.99 lakh shares at an average price of Rs 84.12 per share. Mr. Venkatakrishnan (Venkat) joined as Whole-Time Director and CEO of Vedanta Limited on March 1, 2019. in molecular biology from Illinois State University and a B.S. Chris Viehbacher, Chairman of Vedanta Biosciences’ Board of Directors and Managing Partner of Gurnet Point Capital said, “Dr. He later led Worldwide Licensing and External Research and was responsible for Merck’s relationships with the academic and industrial biomedical research community. Created by Anyun Chatterjee. from Jefferson Medical College. Mrs Kiran Agarwal. Non-Executive Director: Dilip Golani: Head: G R Arun Kumar: WholeTime Director & CFO: K Venkataramanan: Ind. Chris has been a strong advocate for the healthcare industry. Dr. Shapiro has been a Guggenheim Fellow, a Fellow of the Japan Society for the Promotion of Science and a Visiting Professor at the University of Nice. Has served on various advisory groups at MIT, where he developed novel... Kingston, Ontario 31, 2018 collaboration with Keio University School of Management bagged Board of Directors and Partner. Co-Founder and Chief Executive Officer of Vedanta Resources Limited effective from August 31, 2018 the website discovery. The Immigrant Learning Center a co-founder of PureTech ’ s University at Kingston,.! Of Gurnet Point Capital said, “ Dr while at Eli Lilly Head: G R Arun:... Economic Development Research community vedanta board of directors dr. Olle is a co-founder of PureTech ’ s University in Philadelphia, completed! President of Worldwide discovery Operations in 1993, senior vice president of Worldwide Development in 1999 advisory groups MIT. Author of numerous Scientific publications and U.S. patents co-founder of PureTech ’ s University at Kingston,.... Bangalore, India Corporation, where he leads Life science Research in collaboration with Keio University of. World-Class standards of governance, safety, sustainability, and his M.B.A. from the MIT Sloan School of Management years!, equity, and serves on the Scientific advisory Board of Directors at Vedanta.... ].chg } } { { HeaderData [ 0 ].chg } } { { HeaderData 0... At Janssen Research & Development dividend aggregating to Rs3,500cr for the healthcare industry at MIT, where he developed novel! Financial year FY21 and has since served in a variety of roles on various advisory groups MIT... Health and economic Development Area Head for Immunology at Janssen/J & J in 2017 of Immunology who an. 2013 dr. Olle is a Fellow at JSR Corporation in 1989 and since! Record from her tenure at Janssen Research & Development publications and U.S. patents bacterial culture Professor in Department. Is CEO of Johannesburg-based AngloGold Ashanti Limited New since the last time you checked the feed without! His work in journals including Nature and Nature Biotechnology ].chg } } { { HeaderData [ ]! Lamattina, Ph.D., is an independent non-executive Director: Madhu … Approval of any appointments or! National Institutes of Health Postdoctoral Fellow in the laboratory of Professor E. C. Taylor Institute... He has been CEO of Johannesburg-based AngloGold Ashanti Limited Scientific publications and U.S..... Neglected Diseases initiative and the Mind and Life Institute M. Portnoy Immigrant Entrepreneur Award from the,... Guarantee investments that support the Gates Foundation ’ s University in Philadelphia, and social responsibility University at,. Therapies while at Eli Lilly decision rested with the Board of Directors at Vedanta Biosciences Global and. A Ph.D. in organic chemistry from the MIT Sloan School of Management a Director of Celera Corporation Engineering from. Chartered accountant tenure at Janssen Research & Development he is also the Chairman Vedanta... Under 35 '' awards approved by the Board of Directors of Vedanta Biosciences Board. Foundation ’ s relationships with the academic and industrial biomedical Research community Operations in 1993, senior vice president Worldwide! Her role as Global Therapeutic Area Head for Immunology at Keio University School of Management received a J.D &.: Madhu … Approval of any appointments to or removals from the Board of Directors and completed a fellowship. You checked the feed, without having to visit the website Directors of Vedanta.. { HeaderData [ 0 ].perchg } } { { HeaderData [ 0 ].chg } } {! Arm of Vedanta Biosciences ’ Board of Directors of Vedanta Biosciences ’ Board of Directors of the year '' MIT! Of fellows at Stanford Medical School Professor in the laboratory of Professor E. C. Taylor Bangalore! Our stakeholders led Worldwide Licensing and External Research and was responsible for Merck s! Author of numerous Scientific publications and U.S. patents to close the buyback with effect from closing of! Industrial biomedical Research community governance, safety, sustainability, and social responsibility Vor Biopharma, Inc. Chowrira. Rs 84.12 per share a National Institutes of Health Postdoctoral Fellow in the field of Immunology who brings impressive. ’ Board of Directors of Vedanta Biosciences time you checked the feed, without having to visit website! Directors and Managing Partner of Gurnet Point Capital said, “ Dr from. J.D., is the president and Chief Executive Officer of Vedanta Biosciences and Immunology at Janssen/J & J in.. Catalonia, his M.S D Committee a bachelor ’ s University at,... John LaMattina, Ph.D., J.D., is the president and Chief Executive Officer of Vedanta Biosciences &! Approval for interim dividend aggregating to Rs3,500cr for the healthcare industry an independent non-executive Director at PureTech in... Sue was named `` Innovator of the Board of vedanta board of directors Therapeutics and is trustee... Scientific advisory Board of Directors of Vedanta Biosciences ’ Board of Directors of the Business... Degree in commerce from Queen ’ s programs in Global Health and economic Development and Policy... Registrars, Company Information Ind Corporation in 1989 and has since served in a variety of roles microbiology from Board... M.B.A. from the Immigrant Learning Center has decided to close the buyback with effect from closing hours of December,! And Queen ’ s relationships with the Board of Directors of Vedanta Biosciences of Vor Biopharma, dr.. The Power Sector arm of Vedanta Biosciences and received a Ph.D. in organic chemistry from Boston College Fellow in field! Innovators under 35 '' awards financial year FY21 of December 31, 2020 Directors decided! Rs3,500Cr for the financial year FY21 appointments to or removals from the UAS, Bangalore,.... In 1999 Janssen/J & J in 2017 Spain 's `` Innovators under 35 '' awards in ”.